ICGEB Selected for EDCTP3 Stakeholders’ Group, Amplifying Its Role in Shaping Global Health Research
Read More

ICGEB Selected for EDCTP3 Stakeholders’ Group, Amplifying Its Role in Shaping Global Health Research
Read More
Dr. Yan Ge, Principal Investigator at the ICGEB China Regional Research Centre, shares key insights and standout highlights from the Group’s latest research presentations.
Read More
For World TB Day, 24 March 2026, we interviewed Dr. Mariagrazia Di Luca, Head of Antimicrobial Resistance in Trieste
Read More
March 2026, ICGEB Director-General Lawrence Banks visits partner institutes and authorities in Argentina and Uruguay.
Read More
The ICGEB Trieste Molecular Pathology Group has collaborated on a study which has brougt to light a previously unknown neurodevelopmental disorder caused by mutations in SF3B3, a key component of the RNA splicing machinery.
Read More
Vittorio Venturi (ICGEB, Trieste and UM6P, Morocco) has published a Correspondence article in Nature Food proposing a pragmatic strategy to activate Africa’s microbial inoculant sector.
Read More

Following the launch of the BiotechNet II Project in January, a series of awareness workshops has taken place across East Africa.
Read More
From 23 to 27 February 2026, ICGEB hosted a Training Course on Pathogen Detection and Biosecurity at its Headquarters in Trieste, Italy.
Read More
On February 24, 2026, Dr. Lawrence Banks, Director-General of ICGEB, inaugurated BD FACS facility in BSL-III
Read More

On February 20, 2026, Dr. Lawrence Banks, Director-General of ICGEB, inaugurated new research facilities at the ICGEB New Delhi campus, marking a significant milestone in strengthening advanced biotechnology infrastructure at the New Delhi component
Read More